Trusopt

Active Ingredient(s): Dorzolamide
FDA Approved: * December 9, 1994
Pharm Company: * MERCK
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Trusopt Overview

Dorzolamide (trade name Trusopt) is a carbonic anhydrase inhibitor. It is an anti-glaucoma agent, and acts by decreasing the production of aqueous humour.[1] It is administered as a topical ophthalmic in the form of a 2% solution.[2] Contents 1 History 2 Uses 3 Pharmacodynamics 4 Side effects 5 References 6 Further reading History This drug, developed by Merck, was the first drug in human therapy (market introduction 1995) that resulted from structure-...

Read more Trusopt Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Dorzolamide

Recent Trusopt Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Trusopt: (1 result)

Sorted by National Drug Code

• 0006-3519 Trusopt 20 mg/ml Ophthalmic Solution by Merck Sharp & Dohme Corp.

Other drugs which contain Dorzolamide or a similar ingredient: (4 results)

• DORZOLAMIDE 2 discussions
• COSOPT Dorzolamide + Timolol4 discussions
• COSOPT PF Dorzolamide Hydrochloride + Timolol Maleate2 discussions
• DORZOLAMIDE + TIMOLOL